New Mexico-based, Nob Hill Therapeutics, a therapeutic startup and manufacturer of a pulmonary medical device raised $3 million led by Tramway Venture Partners in a Series A.
VIC Technology Venture Development and TCA Venture Group actively backed the round. After the financing, Managing Partner Chris Japp will join as Board Observer at Noob Hill Therapeutic’s board.
Nob Hill Therapeutics Raised $3M Series A
CEO of Nob Hill Therapeutic, Noel Greenberger said that the funds raised will be used for R&D, pre-IND studies, and expansion.
Nob Hill Therapeutics is a health tech company focused on respiratory therapeutics. Nob Hill treats lung diseases with a Dry Powder Nebulizer (a patient technology) that produces drug aerosols and treats respiratory tracts effectively.
Moreover, the Nob Hill Therapeutics inhalation device is patent-protected. It directly gives medicine to the lungs and helps the lungs to function properly.
Also Read: 10 Tips to Protect Yourself From Credit Card Fraud